Richard Haubrich
- Virology top 0.05%
- HIV Research and Treatment 116
- Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 111
- HIV/AIDS Research and Interventions 99
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 26
- Epidemiology top 1%
- HIV, Drug Use, Sexual Risk 12
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Hepatology top 2%
- Hepatitis C virus research 12
-
- Sex work and related issues 9
- Co-authors
- Carol A. KemperMichael M. LedermanDavid KatzensteinJill BlumenthalMichael P. DubéJ. Allen McCutchanDiane V. HavlirMartin Hirsch
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Richard Haubrich
174 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Virology 4.9k
- Infectious Diseases 6.5k
- Emergency Medicine 1.6k
- Epidemiology 2.2k
- Hepatology 444
Countries citing papers authored by Richard Haubrich
This map shows the geographic impact of Richard Haubrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Haubrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Haubrich more than expected).
Fields of papers citing papers by Richard Haubrich
This network shows the impact of papers produced by Richard Haubrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Haubrich. The network helps show where Richard Haubrich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard Haubrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 79 | |
| 4 | 2021 | 3 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 5 | |
| 7 | 2019 | 5 | |
| 8 | 2017 | 25 | |
| 9 | 2014 | 11 | |
| 10 | 2012 | 4 | |
| 11 | 2011 | 3 | |
| 12 | 2011 | 7 | |
| 13 | 2010 | 13 | |
| 14 | TMC125 Safety and Tolerability in Treatment-Experienced, HIV Infected Patients - Pooled DUET Trial Data | 2007 | 2 |
| 15 | 2007 | 96 | |
| 16 | Improved Virologic Response in Three-Class Experienced Patients When an Active Boosted Protease Inhibitor is Used with Enfuvirtide (ENF) | 2005 | 6 |
| 17 | 2001 | 47 | |
| 18 | 2000 | 69 | |
| 19 | 2000 | 11 | |
| 20 | 1998 | 9 |
About Richard Haubrich
Richard Haubrich is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 184 papers that have together received 8.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (116 papers), HIV/AIDS drug development and treatment (111 papers), HIV/AIDS Research and Interventions (99 papers), HIV-related health complications and treatments (26 papers), Hepatitis C virus research (12 papers), HIV, Drug Use, Sexual Risk (12 papers), Sex work and related issues (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). The work is most often cited by research in Virology (4.9k citations), Infectious Diseases (6.5k citations) and Emergency Medicine (1.6k citations). Richard Haubrich has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Carol A. Kemper, Michael M. Lederman, David Katzenstein, Jill Blumenthal, Michael P. Dubé, J. Allen McCutchan, Diane V. Havlir, Martin Hirsch, Sonia Jain and Sharon A. Riddler. Their work appears in journals such as New England Journal of Medicine, The Lancet and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.